Hepion Pharmaceuticals Inc (HEPA)
1.46
-0.06
(-3.95%)
USD |
NASDAQ |
May 03, 16:00
1.46
0.00 (0.00%)
After-Hours: 20:00
Hepion Pharmaceuticals 1 Year Total Returns (Daily): -88.71% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -88.71% |
May 02, 2024 | -88.69% |
May 01, 2024 | -90.07% |
April 30, 2024 | -90.19% |
April 29, 2024 | -90.15% |
April 26, 2024 | -89.93% |
April 25, 2024 | -90.79% |
April 24, 2024 | -90.52% |
April 23, 2024 | -89.65% |
April 22, 2024 | -90.20% |
April 19, 2024 | -87.14% |
April 18, 2024 | -86.53% |
April 17, 2024 | -85.87% |
April 16, 2024 | -86.58% |
April 15, 2024 | -85.66% |
April 12, 2024 | -85.74% |
April 11, 2024 | -84.99% |
April 10, 2024 | -84.38% |
April 09, 2024 | -82.82% |
April 08, 2024 | -81.97% |
April 05, 2024 | -82.26% |
April 04, 2024 | -82.06% |
April 03, 2024 | -82.37% |
April 02, 2024 | -85.25% |
April 01, 2024 | -84.80% |
Date | Value |
---|---|
March 28, 2024 | -81.70% |
March 27, 2024 | -81.59% |
March 26, 2024 | -82.81% |
March 25, 2024 | -83.33% |
March 22, 2024 | -82.75% |
March 21, 2024 | -83.78% |
March 20, 2024 | -83.47% |
March 19, 2024 | -85.21% |
March 18, 2024 | -84.87% |
March 15, 2024 | -84.96% |
March 14, 2024 | -86.61% |
March 13, 2024 | -85.68% |
March 12, 2024 | -85.66% |
March 11, 2024 | -85.26% |
March 08, 2024 | -85.17% |
March 07, 2024 | -86.03% |
March 06, 2024 | -86.12% |
March 05, 2024 | -85.02% |
March 04, 2024 | -83.70% |
March 01, 2024 | -80.06% |
February 29, 2024 | -83.00% |
February 28, 2024 | -84.20% |
February 27, 2024 | -85.06% |
February 26, 2024 | -82.54% |
February 23, 2024 | -83.42% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-96.42%
Minimum
Jul 02 2019
100.9%
Maximum
Aug 10 2020
-50.96%
Average
-56.15%
Median
Oct 31 2023
1 Year Total Returns (Daily) Benchmarks
Ionis Pharmaceuticals Inc | 20.85% |
Madrigal Pharmaceuticals Inc | -24.59% |
Galectin Therapeutics Inc | 98.81% |
Viking Therapeutics Inc | 258.8% |
89bio Inc | -43.95% |